55 research outputs found
Prolactin
During an oral glucose tolerance test (OGTT) glucose and insulin levels were measured in 26 patients with prolactin-producing pituitary tumours without growth hormone excess. Basal glucose and insulin levels did not differ from the values of an age-matched control group. After glucose load the hyperprolactinaemic patients showed a decrease in glucose tolerance and a hyperinsulinaemia. Bromocriptine (CB 154), which suppressed PRL, improved glucose tolerance and decreased insulin towards normal in a second OGTT. — Human PRL or CB 154 had no significant influence on insulin release due to glucose in the perfused rat pancreas. — These findings suggest a diabetogenic effect of PRL. CB 154 might be a useful drug in improving glucose utilization in hormone-active pituitary tumours
Direct Measurement of the Pseudoscalar Decay Constant fD+
The absolute branching fraction of has been directly
measured by an analysis of a data sample of about 33 collected
around GeV with the BES-II at the BEPC. At these energies,
meson is produced in pair as . A total of mesons are reconstructed from this data set. In the
recoil side of the tagged mesons, purely leptonic decay
events of are observed. This yields a branching fraction of
, and a
corresponding pseudoscalar decay constant
MeV.Comment: 7 pages, 8 figures, Submitted to Physics Letters B in October, 200
HISTIDYL-PROLINE DIKETOPIPERAZINE SUPPRESSES PROLACTIN SECRETION IN HUMAN PITUITARY TUMOUR CELL CULTURES
Mammary Development and Pituitary Prolactin Level of Heifers from Birth through Puberty and during the Estrous Cycle
BROMOCRIPTINE TREATMENT OF MALES WITH PITUITARY TUMOURS, HYPERPROLACTINAEMIA, AND HYPOGONADISM
HORMONAL REGULATION OF THE MENSTRUAL CYCLE IN WOMEN WITH BREAST CANCER: EFFECT OF ADJUVANT CHEMOTHERAPY
ALTERATIONS IN SERUM PROLACTIN HETEROGENEITY BY PROVOCATIVE TESTS IN A PATIENT WITH A PITUITARY TUMOUR
- …